Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor Elías Jatem Escalante, Alfons Segarra Medrano, Clara Carnicer Cáceres, M. Adoración Martín-Gómez, María Teresa Salcedo Allende, Helena Ostos Roldan, Irene Agraz Pamplona

Evolution of antibody titre against the M-type phospholipase A2 receptor and clinical response in idiopathic membranous nephropathy patients treated with tacrolimus Alfons Segarra-Medrano, Elias Jatem-Escalante, Clara Carnicer-Cáceres, Irene Agraz-Pamplona, M. Teresa Salcedo, Naiara Valtierra, Elena Ostos-Roldán, Karla V. Arredondo, Juliana Jaramillo

A comparison of cyclophosphamide versus tacrolimus in terms of treatment effect for idiopathic membranous nephropathy: A meta-analysis Yan-Chun Li, Jing Huang, Xin Li, Su-Mei Zhao